British Journal of Haematology

Pituitary apoplexy during induction chemotherapy for acute myeloid leukaemia
pp. 151-151(1)
Authors: Silberstein, L.; Johnston, C.; Bhagat, A.; Tibi, L.; Harrison, J.

Schnitzler syndrome
pp. 152-152(1)
Authors: Cascavilla, Nicola; D'Arena, Giovanni; Dell'Olio, Matteo

Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia
pp. 153-168(16)
Authors: Van Vlierberghe, Pieter; Pieters, Rob; Beverloo, H. Berna; Meijerink, Jules P. P.

Cytotoxic T lymphocytes as immune-therapy in haematological practice
pp. 169-179(11)
Authors: Leen, Ann M.; Heslop, Helen E.

Virchow and his triad: a question of attribution
pp. 180-190(11)
Authors: Bagot, Catherine N.; Arya, Roopen

Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial
pp. 191-200(10)
Authors: Pönisch, Wolfram; Rozanski, Marta; Goldschmidt, Hartmut; Hoffmann, Franz Albert; Boldt, Thomas; Schwarzer, Andreas; Ritter, Ute; Rohrberg, Robert; Schwalbe, Elke; Uhlig, Jens; Zehrfeld, Thomas; Schirmer, Veronika; Haas, Antje; Kreibich, Ute; Niederwieser, Dietger

A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma
pp. 201-209(9)
Authors: O'Connor, Owen A.; Portlock, Carol; Moskowitz, Craig; Straus, David; Hamlin, Paul; Stubblefield, Michael; Dumetrescu, Otila; Colevas, A. Dimitrios; Grant, Barbara; Zelenetz, Andrew

Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes
pp. 210-221(12)
Authors: Schraders, Margit; Jares, Pedro; Bea, Silvia; Schoenmakers, Eric F. P. M.; van Krieken, Johan H. J. M.; Campo, Elias; Groenen, Patricia J. T. A.

Characterisation of haematological profiles and low risk of thromboembolic events with bortezomib in patients with relapsed multiple myeloma
pp. 222-229(8)
Authors: Lonial, Sagar; Richardson, Paul G; San Miguel, Jesús; Sonneveld, Pieter; Schuster, Michael W; Bladé, Joan; Cavenagh, Jamie; Rajkumar, S. Vincent; Jakubowiak, Andrzej J; Esseltine, Dixie-Lee; Anderson, Kenneth C; Harousseau, Jean-Luc

Rapid and sensitive screening for CEBPA mutations in acute myeloid leukaemia
pp. 230-239(10)
Authors: Benthaus, Tobias; Schneider, Friederike; Mellert, Gudrun; Zellmeier, Evelyn; Schneider, Stephanie; Kakadia, Purvi M.; Hiddemann, Wolfgang; Bohlander, Stefan K.; Feuring-Buske, Michaela; Braess, Jan; Spiekermann, Karsten; Dufour, Annika

Reduction of B cell turnover in chronic lymphocytic leukaemia
pp. 240-247(8)
Authors: Defoiche, Julien; Debacq, Christophe; Asquith, Becca; Zhang, Yan; Burny, Arsène; Bron, Dominique; Lagneaux, Laurence; Macallan, Derek; Willems, Luc

The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival
pp. 248-252(5)
Authors: Wang, Xiao; Asplund, A. Charlotta; Porwit, Anna; Flygare, Jenny; Smith, C. I. Edvard; Christensson, Birger; Sander, Birgitta

The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in `Western' patients with intravascular large B-cell lymphoma
pp. 253-257(5)
Authors: Ferreri, Andrés J. M.; Dognini, Giuseppina P.; Bairey, Osnat; Szomor, Arpad; Montalbán, Carlos; Horvath, Barbara; Demeter, Judit; Uziel, Lilj; Soffietti, Riccardo; Seymour, John F.; Ambrosetti, Achille; Willemze, Rein; Martelli, Maurizio; Rossi, Giuseppe; Candoni, Anna; De Renzo, Amalia; Doglioni, Claudio; Zucca, Emanuele; Cavalli, Franco; Ponzoni, Maurilio

Aplastic anaemia in association with coeliac disease: a series of three cases
pp. 258-260(3)
Authors: Grey-Davies, E.; Hows, J. M.; Marsh, J. C. W.

Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children's Oncology Group
pp. 261-267(7)
Authors: Abromowitch, Minnie; Sposto, Richard; Perkins, Sherrie; Zwick, David; Siegel, Stuart; Finlay, Jonathan; Cairo, Mitchell S.

Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma
pp. 268-273(6)
Authors: Costa, Luciano J.; Micallef, Ivana N.; Inwards, David J.; Johnston, Patrick B.; Porrata, Luis F.; Litzow, Mark R.; Ansell, Stephen M.

A multicentre randomised clinical endpoint study ofparma5 computer-assisted oral anticoagulant dosage
pp. 274-283(10)
Authors: Poller, Leon; Keown, Michelle; Ibrahim, Saied; Lowe, Gordon; Moia, Marco; Turpie, Alexander G.; Roberts, Christopher; van den Besselaar, Aton M. H. P.; van der Meer, Felix J. M.; Tripodi, Armando; Palareti, Gualtiero; Jespersen, Jørgen

Polymorphisms of the Z protein protease inhibitor and risk of venous thromboembolism: a meta-analysis
pp. 284-287(4)
Authors: Dentali, Francesco; Gianni, Monica; Lussana, Federico; Squizzato, Alessandro; Cattaneo, Marco; Ageno, Walter

Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean
pp. 288-293(6)
Authors: Grann, Victor R.; Ziv, Elad; Joseph, Cecil K.; Neugut, Alfred I.; Wei, Ying; Jacobson, Judith S.; Horwitz, Marshall S.; Bowman, Natalie; Beckmann, Kenneth; Hershman, Dawn L.

Rituximab in the treatment of autoimmune haematological disorders
pp. 294-294(1)
Authors: Provan, Drew; Newland, Adrian C.; Amadori, Sergio; Stasi, Roberto

Rituximab in the treatment of autoimmune haematological disorders - response to Provan et al
pp. 295-295(1)
Author: Garvey, Bernadette

Chronic lymphocytic leukaemia: an overview of aetiology - comment
pp. 295-296(2)
Author: Muirhead, Colin R.

Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up
pp. 296-298(3)
Authors: Cervetti, Giulia; Galimberti, Sara; Andreazzoli, Francesca; Fazzi, Rita; Cecconi, Nadia; Caracciolo, Francesco; Petrini, Mario

Functional analysis of protein Z (Arg255His) and protein Z-dependent protease inhibitor (Lys25Arg and Ser40Gly) polymorphisms
pp. 298-300(3)
Authors: Ndonwi, Matthew; Lu, Lan; Tu, Yizheng; Phillips, Michelle; Broze Jr, George

Megakaryocyte hyperproliferation without GATA1 mutation in foetal liver of a case of Down syndrome with hydrops foetalis
pp. 300-303(4)
Authors: De Vita, Serena; Devoy, Anny; Groet, Juergen; Krušlin, Božo; Kuzmić-Prusac, Ivana; Nižetić, Dean

Corrigendum
pp. 304-304(1)